1[1]Figer A, Karasik YP, Baruch RG, et al. Insulin-like growth factor I polymorphism and cancer risk in Jewish women. Isr Med Assoc J,2002,4:759-762.
2[5]Mamay CL, Mingo Sion, Wolf DM, et al. An inhibitory fuction for JNK in the regulation of IGF-I signaling in breast cancer. Oncogene, 2003,223:602-614.
3[3]Kleinmann D, Karas M, Danilenko NA, et al. Stimulation of endomtrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor IGF-I induced tyrosine phosphorylation and reduction in IGF binding proteins. Endocrinology,2002,137:1089-1095.
4[4]Schindler AE. Progestins and the endometrium. Zentralbl Gynakol,2001,119:59-63.
5[2]Wu XK,Zhou SY,Liu JX,et al.Selective ovary resistance to in sulin signaling in women with polycystic ovary syndrome.Fertil steril,2003,80:954-965.
6[6]Stergios J, Moschos Christos S. Mantzoros.The role of IGFsystem in cancer:from basic to clinical studies and clinical applications. Oncology, 2002, 63:317-332.
7Weisz A,Bresciani F.Estrogen regulation of proto-oncogene coding for nuclear proteins. Critical Reviews in Oncogenesis . 1993
8Castoria G,Barone MV,Domenico MD,et al.Nontranscriptional action of estradiol and progestin triggers DNA synthesis. EMBO Journal . 1999
9Risinger JI,Hayes AK,Berchuck A,et al.PTEN/MMAC1 mutations in endometrial cancers. Cancer Research . 1997
10Mutter GL,Lin MC,Fitzgerald JT,et al.Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. Journal of the National Cancer Institute . 2000
